Robin Feldman

Drug Wars (eBook, PDF)

How Big Pharma Raises Prices and Keeps Generics off the Market

• Format: PDF

Produktbeschreibung

While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Cambridge University Press
• Erscheinungstermin: 9. Juni 2017
• Englisch
• ISBN-13: 9781316731772
• Artikelnr.: 53153577

Autorenporträt

Robin Feldman is an award-winning teacher and scholar who has published more than forty articles and books. Feldman has been cited by the White House, members of Congress, and numerous federal agencies, and she has testified before committees of the US House and Senate, as well as the California legislature. In 2016, Feldman was named as one of the Women Leaders in Law and Technology, the only academic to receive the honor.

Inhaltsangabe

Introduction: big scandals, higher prices
1. The winding road to generic entry
2. 'Generation 1.0': the rise and fall of traditional pay-for-delay
3. 'Generation 2.0': complicating pay-for-delay
4. 'Generation 3.0': new tactics for active obstruction of generics
5. 'Generation 3.0' continued: obstruction of regulatory pathways
6. Empirical evidence of a citizen's pathway gone astray
Conclusion: a call for systematic reform.